Skip to content

A Randomized study of vagus nerve stimulation to reduce distress in people with tinnitus

To evaluate the efficacy of Vagus Nerve Stimulation (VNS) in reducing tinnitus-related distress: A Randomised Control Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101415
Enrollment
150
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H838- Other specified diseases of innerear

Interventions

Intervention1: Transcutaneous vagus nerve stimulation with sound therapy and tinnitus educational counselling: Participants will receive transcutaneous vagus nerve stimulation delivered using a non in

Sponsors

Sagrika Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects within age range of 18-55 years with subjective (can be heard only by oneself) and chronic (greater than 3 months) tinnitus which is continuous in both or one ear. These subjects can be with or without hearing loss, but hearing loss not exceeding more than 50 dBHL in all frequencies i.e. 250 Hz, 500 Hz, 1000 Hz, 2000 Hz, 4000 Hz and 8000 Hz.

Exclusion criteria

Exclusion criteria: subjects with intermittent (not continuous throughout) or pulsatile tinnitus (vascular in origin) or can be heard by others (objective tinnitus). Subjects having any other otological disorder like Meniere s disease or otosclerosis, neuropsychiatric, respiratory, or cardiac issues. Subjects with implanted device such as pacemaker or any neurostimulation device

Design outcomes

Primary

MeasureTime frame
Tinnitus-related distress measured using Tinnitus Functional IndexTimepoint: Baseline 1-month follow-up 3-month follow-up

Secondary

MeasureTime frame
Tinnitus severity measured using Tinnitus Handicap InventoryTimepoint: Baseline 1-month follow-up 3-month follow-up;Perceived tinnitus loudness measured using visual analogue scaleTimepoint: Baseline 1-month follow-up 3-month follow-up;Sleep quality and stress using validated questionnaireTimepoint: Baseline 1-month follow-up 3-month follow-up;Electrophysiological tests like P300 and MMNTimepoint: Baseline 1-month follow-up 3-month follow-up

Countries

India

Contacts

Public ContactSanjay Kumar Munjal

PGIMER

sanjaymunjal1@hotmail.com9815653262

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026